The study showed that the test improved care of patients with moderate to severe depression.
The company will continue clinical trials to evaluate the efficacy of the Doraya temporary venous catheter system.
The breakthrough status was granted for diagnosis of normal pressure hydrocephalus patients and prediction of response to VPS.
The radioactive diagnostic agent is indicated for PET of PSMA-positive lesions in men with prostate cancer.
The 32HQ713D monitor provides sharp and clear images with deeper blacks.
Give your business an edge with our leading industry insights.
The Guardant360 CDx CGP blood test facilitates personalised treatment decisions for patients with advanced solid cancers.
The study demonstrated a 9.3% reduction in all-cause healthcare resource utilisation rates in Dario users, compared to non-users.
The company will develop a Covid-19 and Influenza A/B combo test that will employ lateral-flow assay (LFA) technology.
The companies intend to increase the availability of NGS-based testing for cancer patients.
The two companies will assess the feasibility of potential therapeutic applications and subsequent product development.